Results 121 to 130 of about 33,261 (251)

Plasma Aryl Hydrocarbon Receptor Agonist Activity Is Associated With Inflammation and Metabolic Dysregulation in Obesity: A Cross-Sectional Study. [PDF]

Diabetes Metab Res Rev
Bahman F, Kochumon S, Al Madhoun A, Al-Roub A, Bennakhi A, Arouj M, Al-Mulla F, Ahmad R.   +7 more
europepmc   +1 more source

Aryl Hydrocarbon Receptor [PDF]

, 2011
openaire   +1 more source

Advancing Type 1 Diabetes Treatment: 3 PM‐Oriented Innovations in Islet Transplantation and Biomaterial Engineering

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 6, September 2026.
ABSTRACT Type 1 Diabetes (T1D) is an autoimmune disorder marked by the immune‐mediated destruction of pancreatic β‐cells, resulting in insulin deficiency and dysregulated glucose control. Current therapies—such as insulin replacement and artificial pancreas systems—manage symptoms but fail to restore endogenous β‐cell function or halt disease ...
Fatemeh Sabet Sarvestani, Ramin Yaghobi, Mohsen Khosravi Maharlooei, Mehdi Golshan, Mohammad Hossein Karimi   +4 more
wiley   +1 more source

A Review of Aryl Hydrocarbon Receptor-Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progression. [PDF]

Immunotargets Ther
Han H, Dong Q, Zhang Z, Li S, Zhang H, Wang X, Bai J, Shi L, Fu X, Zheng K, Liang L.   +10 more
europepmc   +1 more source

A Physical Organic Odyssey: From the Ultrafast Dynamics of Carbenes and Nitrenes to Contemporary Chemical Biology and Drug Discovery

Journal of Physical Organic Chemistry, Volume 39, Issue 9, September 2026.
Physical organic chemistry transforms photoaffinity labeling from empirical photochemistry into rational probe design. By measuring reactive‐intermediate lifetimes, pathways, and selectivity, Platz's legacy connects carbene and nitrene mechanisms to modern chemoproteomics, enabling more precise protein labeling and drug‐discovery maps.
Bin Yang, Jin Wang
wiley   +1 more source

The aryl hydrocarbon receptor: A modulator of skeletal muscle health and aging. [PDF]

Biochimie
Wimberly K, Ryan TE.
europepmc   +1 more source

An Update on Advancement in Genomics Resources for Spiny Lobster Aquaculture Development

Reviews in Aquaculture, Volume 18, Issue 4, September 2026.
ABSTRACT The rapid advancement of high‐throughput sequencing technologies has transformed aquaculture genomics, enabling unprecedented insights into the biology and improvement of non‐model aquatic species. Among crustaceans, lobsters represent one of the most commercially valuable yet genomically underexplored taxa. This review synthesises the current
Courtney Lewis, Ahmad Farhadi, Susan Glendinning, Thomas Banks, Tara Kelly, Andrew G. Jeffs, Sandra Infante Villamil, John Breen, Jennifer M. Cobcroft, Arya Vazirzadeh, Basseer M. Codabaccus, Chris G. Carter, Quinn P. Fitzgibbon, Gregory G. Smith, Tomer Ventura   +14 more
wiley   +1 more source

Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma

Advanced Science, Volume 13, Issue 44, 7 August 2026.
This review explains how chronic liver injury progresses toward hepatocellular carcinoma through interconnected changes in gut microbes, metabolism, immunity, fibrosis, and diet. It highlights microbial metabolites, bile‐acid signaling, immune dysfunction, and nutritional or microbiome‐based interventions as opportunities to identify risk earlier ...
Yi Hu, Caiyan Lin, Lijie Zhang, Xue Jiang, Huawen Li, Yangzhe Wu   +5 more
wiley   +1 more source

The landscape of biased agonism in aryl hydrocarbon receptor signaling: current clues and future directions. [PDF]

Front Pharmacol
Dvořák Z, Přikryl J.
europepmc   +1 more source

The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation

American Journal of Hematology, Volume 101, Issue 8, Page 1980-1996, August 2026.
ABSTRACT Allogeneic hematopoietic cell transplantation (allo‐HCT) is an effective treatment for patients with high‐risk hematologic malignancies. Over the last decade, gut microbiota composition during allo‐HCT has been associated with patients' outcomes.
Wenjing Hao, Nicolas Stocker, Béatrice Gaugler, Mohamad Mohty, Florent Malard   +4 more
wiley   +1 more source